Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
D000818:Animals; D001011:Aorta / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000378:metabolism; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D003331:Coronary Vessels / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood; D009531:Niceritrol / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009540:Nicotinyl Alcohol / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D013552:Swine; D014280:Triglycerides / Q000097:blood
D008074:Lipoproteins; D009539:Nicotinic Acids; D011725:Pyridines; D014280:Triglycerides; D002784:Cholesterol; D009540:Nicotinyl Alcohol; D009531:Niceritrol